Literature DB >> 856012

Netilmicin and gentamicin: comparative pharmacology in humans.

L J Riff, G Moreschi.   

Abstract

Thirteen male subjects received 1 mg of either gentamicin or netilmicin per kg, first intramuscularly and then intravenously. After the intramuscular dose, concentrations of gentamicin in the serum were more variable than those of netilmicin. After the intravenous dose, the distribution phase of netilmicin was twice as rapid as gentamicin. The average half-times of the elimination phase were similar, but there was marked variability among the subjects receiving gentamicin. Serum clearance of netilmicin was more rapid than that of gentamicin and could not be attributed to renal elimination. The data indicate that, after intramuscular administration, netilmicin may produce more predictable blood levels than gentamicin and suggest that the body distribution of netilmicin may differ from that of gentamicin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 856012      PMCID: PMC352037          DOI: 10.1128/AAC.11.4.609

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

Review 1.  Clinical pharmacokinetics (second of two parts).

Authors:  D J Greenblatt; J Koch-Weser
Journal:  N Engl J Med       Date:  1975-11-06       Impact factor: 91.245

2.  The mild hemophilias. Occult deficiencies of AHF, PTC and PTA frequently responsible for unexpected surgical bleeding.

Authors:  P M AGGELER; M S HOAG; R O WALLERSTEIN; D WHISSELL
Journal:  Am J Med       Date:  1961-01       Impact factor: 4.965

3.  Absorption of atropine from muscle.

Authors:  H SCHRIFTMAN; A A KONDRITZER
Journal:  Am J Physiol       Date:  1957-12

4.  Pharmacology of gentamicin in man.

Authors:  L J Riff; G G Jackson
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

5.  Comparative in vitro activity of Sch 20656, netilmicin, gentamicin, and tobramycin.

Authors:  C Watanakunakorn
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

6.  In vitro study of netilmicin compared with other aminoglycosides.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

7.  In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.

Authors:  S A Kabins; C Nathan; S Cohen
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

8.  Sisomicin versus netilmicin: in vitro susceptibility testing.

Authors:  D J Flournoy
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

9.  Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.

Authors:  M I Marks; S Hammerberg; G Greenstone; B Silver
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

10.  In vitro synergistic effect of netilmicin, a new aminoglycoside antibiotic.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

View more
  17 in total

1.  High-pressure liquid chromatographic assay of netilmicin in plasma.

Authors:  G W Peng; G G Jackson; W L Chiou
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

2.  Clinical pharmacology of netilmicin.

Authors:  B S Yap; D Stewart; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

Review 3.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

5.  Pharmacokinetics of netilmicin in renal insufficiency and haemodialysis.

Authors:  J C Pechere; R Dugal; M M Pechere
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

6.  Clinical pharmacology of netilmicin in the newborn.

Authors:  A M Phillips; R D Milner
Journal:  Arch Dis Child       Date:  1983-06       Impact factor: 3.791

7.  Assay of netilmicin, using enzyme immunoassay for gentamicin.

Authors:  T Larson; D N Gerding; L R Peterson; J H Eckfeldt
Journal:  Antimicrob Agents Chemother       Date:  1982-03       Impact factor: 5.191

8.  Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.

Authors:  B V Bock; P H Edelstein; R D Meyer
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

9.  Predicted tissue accumulation of netilmicin in patients.

Authors:  D J Edwards; A Mangione; T J Cumbo; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

10.  Netilmicin: clinical efficacy, tolerance, and toxicity.

Authors:  A P Panwalker; J B Malow; V M Zimelis; G G Jackson
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.